Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Altavilla

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
British Journal of Pharmacology|May 12, 2000
Protective effects of cyclosporin-A in splanchnic artery occlusion shockF Squadrito, D Altavilla, G Squadrito, et al.
Cardiovascular Research|August 30, 2000
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injuryD Altavilla, B Deodato, G M Campo, et al.
British Journal of Pharmacology|August 13, 2008
Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiolA Bitto, B P Burnett, F Polito, et al.
International Journal of Andrology|June 10, 2011
Effects of polydeoxyribonucleotide on the histological damage and the altered spermatogenesis induced by testicular ischaemia and reperfusion in ratsL Minutoli, P Antonuccio, F Squadrito, et al.
British Journal of Pharmacology|October 12, 1999
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shockF Squadrito, S Guarini, D Altavilla, et al.
Free Radical Biology & Medicine|May 23, 2001
Oxidative stress causes nuclear factor-kappaB activation in acute hypovolemic hemorrhagic shockD Altavilla, A Saitta, S Guarini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 28, 2009
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up studyH Marini, A Bitto, D Altavilla, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
British Journal of Pharmacology|May 12, 2000
Protective effects of cyclosporin-A in splanchnic artery occlusion shockF Squadrito, D Altavilla, G Squadrito, et al.
Cardiovascular Research|August 30, 2000
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injuryD Altavilla, B Deodato, G M Campo, et al.
British Journal of Pharmacology|August 13, 2008
Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiolA Bitto, B P Burnett, F Polito, et al.
International Journal of Andrology|June 10, 2011
Effects of polydeoxyribonucleotide on the histological damage and the altered spermatogenesis induced by testicular ischaemia and reperfusion in ratsL Minutoli, P Antonuccio, F Squadrito, et al.
British Journal of Pharmacology|October 12, 1999
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shockF Squadrito, S Guarini, D Altavilla, et al.
Free Radical Biology & Medicine|May 23, 2001
Oxidative stress causes nuclear factor-kappaB activation in acute hypovolemic hemorrhagic shockD Altavilla, A Saitta, S Guarini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 28, 2009
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up studyH Marini, A Bitto, D Altavilla, et al.
Pageof 12